Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

<div>Allopurinol altered gene expression is PSE cells, 2 days post treatment. Data is expressed relative to the control-treated cells (<span class="inline" id="M54"></span>, <span class="inline" id="M55"></span>). Bars with asterisks are significantly different than the control-treated cells (<span class="inline" id="M56"></span>, Dunnett’s multicomparison test).</div>

BioMed Research International

fig2

Figure 2

Figure 2: Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis 

Figure 2 | Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis 